Abstract

    Open Access Mini Review Article ID: IJPSDR-6-128

    Bacteriocin-like protein produced Brevibacillus laterosporus that can inhibit the growth of drug resistant bacteria

    Monthon Lertcanawanichakul* and Kittisak Chawawisit

    This minireview contains a compendium of bacteriocin or bacteriocin-like proteins produced from Brevibacillus laterosporus that can inhibit the growth of drug resistant bacteria. A good number of bacterial secondary metabolites/ bacteriocin/ bacteriocin-like proteins are reported to have anti-drug resistant bacteria activity or anti-cancer activity comparable to the existing chemical synthesis antimicrobial drugs or sometimes even better. Information regarding the mode of action of bacteriocin leads to insight into their activity relationship and potency. A further well defined strategy is required to exploit these active molecules used as anti-drug resistant bacteria drugs.

    Keywords:

    Published on: Jun 3, 2020 Pages: 12-15

    Full Text PDF Full Text HTML DOI: 10.17352/ijpsdr.000028
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat

    Indexing/Archiving

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJPSDR

    Google Reviews 11